Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm

Thrombosis Research

Volumn 106, Issue 2, 2002, Pages 131-136

  Schillinger, Martin ^a   Exner, Markus ^a   Mlekusch, Wolfgang ^a   Domanovits, Hans ^a   Huber, Kurt ^a   Mannhalter, Christine ^a   Wagner, Oswald ^a   Minar, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abdominal aortic aneurysm; Gene polymorphism; GT dinucleotide repeats; Heme oxygenase 1

Indexed keywords

HEME OXYGENASE 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENZYME REGULATION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; TANDEM REPEAT;

ALLELES; AORTIC ANEURYSM, ABDOMINAL; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MALE; MEMBRANE PROTEINS; MINISATELLITE REPEATS; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037089056     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00100-7     Document Type: Article

References (37)

1. Rasmussen T.E., Hallett J.W. New insights into inflammatory aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 14:1997;329-332.
2. Pennel R.C., Hollier L.H., Lie J.T. Inflammatory abdominal aortic aneurysms: a thirty-year review. J. Vasc. Surg. 2:1985;859-869.
3. Sterpetti A.V., Hunter W.J., Feldhaus R.J. Inflammatory aneurysm of the abdominal aorta: incidence, pathologic, and etiologic considerations. J. Vasc. Surg. 9:1989;643-650.
4. Grange J.J., Davis V., Baxter B.T. Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc. Surg. 5:1997;256-265.
5. Rohde L.E., Arroyo L.H., Rifai N., Creager M.A., Libby P., Ridker P.M.et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler. Thromb. Vasc. Biol. 19:1999;1695-1699.
6. Satta J., Laurila A., Paakko P., Haukipuro K., Sormunen R., Parkkila S.et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur. J. Vasc. Endovasc. Surg. 15:1998;313-319.
7. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H.et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Atheroscler. Thromb. Vasc. Biol. 17:1997;2843-2847.
8. Davis V., Persidskaia R., Baca Regen L., Itoh Y., Nagase H., Persidsky Y.et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18:1998;1625-1633.
9. Rehm J.P., Grange J.J., Baxter B.T. The formation of aneurysms. Semin. Vasc. Surg. 11:1998;193-202.
10. Miralles M., Wester W., Sicard G.A., Thompson R., Reilly J.M. Indomethacin inhibits expansion of experimental aortic aneurysm via inhibition of the cox2 isoform of cyclooxygenase. J. Vasc. Surg. 29:1999;884-892.
11. Curci J.A., Petrinec D., Liao S., Golub L.M., Thompson R.W. Pharmacologic suppression of experimental aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J. Vasc. Surg. 28:1998;1082-1093.
12. Bigatel D.A., Elmore J.R., Carey D.J., Cizmeci Smith G., Franklin D.P., Youkey J.R. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J. Vasc. Surg. 29:1999;130-138.
13. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical application. FASEB J. 2:1988;2557-2568.
14. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 244:1969;6388-6394.
15. Otterbein L.E., Bach F.H., Alam J., Soares M., Lu A.T., Wysk M.et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:2000;422-428.
16. Wang L.J., Lee T.S., Lee F.Y., Pai R.C., Chau L.Y. Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152:1998;711-720.
17. Kimpara T., Takeda A., Watanabe K., Itoyama Y., Ikawa S., Watanabe M.et al. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet. 100:1997;145-147.
18. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S.et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66:2000;187-195.
19. Exner M., Schillinger M., Minar E., Mlekusch W., Schlerka G., Haumer M.et al. Heme oxygenase-1 microsatellite gene promoter polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J. Endovasc. Ther. 8:2001;433-440.
20. Schillinger M., Exner M., Mlekusch W., Ahmadi R., Rumpold H., Mannhalter C.et al. Heme oxygenase-1 genotype is a vascular anti-inflammatory factor after balloon angioplasty. J. Endovasc. Ther. 2002;. (in press).
21. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., Stanley J.C. Suggested standard for reporting on arterial aneurysms. J. Vasc. Surg. 13:1991;452-458.
22. Rader D., Puré E. Genetic susceptibility to atherosclerosis. Insights from mice. Circ. Res. 86:2000;1013-1015.
23. Yuko T., Morita T., Suematsu M., Ishimura Y., Yamazaki J.I., Katayama S. Protective role of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am. J. Physiol. 278:2000;H623-H632.
24. Morita T., Kourembanas S. Endothelial expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 96:1995;2676-2682.
25. Morita T., Mitsialis S.A., Liu Y., Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J. Biol. Chem. 52:1997;32804-32809.
26. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T.et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:1999;129-135.
27. Siouw R.C.M., Sato H., Mann G.E. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc. Res. 41:1999;385-394.
28. Nakayama M., Takahashi K., Komura T., Fukuchi M., Shioiri H., Sato K.et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 21:2001;1373-1377.
29. Ishikawa K., Navab M., Leitinger N., Fogelman A.M., Aldons J.L. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100:1997;1209-1216.
30. n sequences upstream of the rat prolactin gene from Z-DNA and inhibit gene transcription. Nucleic Acids Res. 18:1990;1595-1601.
31. Okinaga S., Takahashi K., Takeda K., Yoshizawa M., Fujita H., Sasaki H.et al. Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood. 87:1996;5074-5084.
32. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:1996;87-90.
33. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipid peroxidation. J. Biol. Chem. 269:1994;16712-16719.
34. Wu T.W., Fung K.P., Wu J., Yang C.C., Weisel R.D. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem. Pharmacol. 51:1996;859-862.
35. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
36. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edward P.A.et al. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
37. Funke H., Assmann G. Strategies for the assessment of genetic coronary artery disease risk. Curr. Opin. Lipidol. 10:1999;285-291.